Glucotrack (GCTK) EPS (Basic) Growth (3y) (2013 - 2026)
Powered by 
Analysis
Glucotrack (GCTK) EPS (Basic) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | -12.28% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 24.18% |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 24.57% |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 19.63% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 50.64% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | -6.23% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | 29.56% |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | 17.98% |
| 10 | Glucotrack | 1.06 Mn | -68,752.73 | - | -26.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.02% |
| Dec 31, 2025 | -26.23% |
| Sep 30, 2025 | -26.27% |
| Jun 30, 2025 | -26.46% |
| Mar 31, 2025 | 63.47% |
| Dec 31, 2024 | -6.29% |
| Sep 30, 2024 | -33.09% |
| Jun 30, 2024 | -42.78% |
| Mar 31, 2024 | -26.93% |
| Dec 31, 2023 | 58.71% |
| Sep 30, 2023 | 54.40% |
| Jun 30, 2023 | 63.47% |
| Mar 31, 2023 | -15.24% |
| Dec 31, 2022 | -46.38% |
| Sep 30, 2022 | 40.26% |
| Jun 30, 2022 | 43.22% |
| Mar 31, 2022 | -40.31% |
| Dec 31, 2021 | 60.74% |
| Sep 30, 2021 | 73.14% |
| Jun 30, 2021 | 75.24% |